New York, USA – October 20, 2022 – Research revealed that no mRNA vaccines for COVID-19 are without lipid shells. As a leader in the field of RNA technology and liposomal development, BOC Sciences announces to offer the one-stop liposomal drug delivery service to power the generation of effective drugs and vaccines for COVID-19 treatment and prevention.
Liposomes are small, artificial, and sphere-shaped vesicles that are created utilizing cholesterol and non-toxic phospholipids. Due to the amphiphilic nature of liposomes, they can serve as specialized delivery vehicles that enhance and prolong the capabilities of active pharmaceutical ingredients (APIs). In general, the use of the liposomal drug delivery system is advanced by:
• Non-toxicity, biocompatibility, and complete biodegradability
• Enhanced drug efficacy
• Site avoidance effect
• Reduced drug toxicity
• Flexibility for active targeting
BOC Sciences has extensive expertise and experience in RNA & liposomal technology and can provide the most suitable advice and solutions to researchers in demand of drug delivery and vaccine development for COVID-19, including mRNA vaccine design and synthesis, liposome preparation, drug loading (passive loading or active loading), and antifreeze for liposomes. The company has developed a liposomal drug delivery system that can achieve stable drug molecule encapsulation and improve delivery efficiency to maximize physiological effects and health benefits.
At BOC Sciences, its team of scientists can design and synthesize mRNA sequences from DNA templates and afford laboratory-scale or GMP-level mRNA vaccines. In addition, the company is able to prepare liposomes through diverse manufacturing strategies, including sonication, ultrasonication, French pressure cell press, extrusion, membrane extrusion, and lipid film hydration. Moreover, it can load drugs or vaccines into liposomes based on the mRNA vaccine developed in cooperation. If clients already have drug candidates, BOC Sciences can also provide liposomal encapsulation services and help prepare loaded liposomes.
With high-quality raw materials in stock and strict quality control procedures, BOC Sciences can help customers save time and workload in the development of COVID-19 drugs and vaccines and enhance the productivity and reliability of project outputs. Last but not least, all final products are sterilized and packed in autoclaved sterile vials to ensure long-term stability.
About Liposomal Drug Delivery System
A growing number of research applications have utilized liposomal molecules as drug delivery systems due to their biocompatibility, biodegradability, low toxicity, non-immunogenicity, and the ability to trap both hydrophilic and lipophilic drugs, thus simplifying site-specific drug delivery for tumor tissues. With joint efforts, BOC Sciences can help accelerate COVID-19 vaccine and drug programs for researchers through efficient and cost-effective solutions.
Media ContactCompany Name: BOC SciencesContact Person: Alex BrownEmail: Send EmailPhone: 1-631-485-4226Country: United StatesWebsite: https://rna.bocsci.com